GlassScriptPhysician profile
Jennifer Goss
NPI 1710180906
$580.11
in general payments reported to CMS, 2019-2025
12 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2021: $60.13 · 2022: $138 · 2023: $24.49 · 2024: $72.33 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $247.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $123.36 | 2022 | |
| Hologic Sales and Service, LLC | $109.42 | 2021-2025 | Myosure Tissue Removal Device, Acessa Provu System, Fluent Fluid Management System |
| Roche Diagnostics Corporation | $69.39 | 2019 | |
| Abbvie INC. | $65.37 | 2019-2021 | |
| Biogen, INC. | $60.37 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $36.93 | 2025 | |
| Astellas Pharma US INC | $32.38 | 2024 | Veozah |
| Exeltis, USA INC. | $24.49 | 2023 | Slynd |
| Sumitomo Pharma America, INC. | $19.38 | 2024 | Myfembree |
| Coloplast Corp | $14.15 | 2022 | |
| Avion Pharmaceuticals | $13.98 | 2019 | |
| Pfizer INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Goss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.